Cordis PRECISE (R) PRO RX Nitinol Stent System (Carotid)

Recall Insight

This FDA Devices action (record #Z-1946-2016) was formally reported on June 22, 2016, with the manufacturer initiating the action on May 4, 2016. It is classified under Moderate severity (Class II), with a current status of Terminated. Cordis Corporation is listed as the recalling firm, operating out of Miami Lakes, FL. Federal records indicate 4,400 units in US and 3,100 units in Foreign Countries units are affected, placing this recall in the million-unit bracket that typically triggers nationwide consumer alerts and retailer sweeps.

The documented reason for this recall is: Inability to deploy the stent or partial stent deployment. Distribution data in the federal record shows the product reached: NATIONWIDE and FOREIGN CONSIGNEES: Japan, Taiwan, Thailand and South Korea.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 10 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.